Propagation of Parkinson's disease by extracellular vesicle production and secretion
Open Access
- 16 September 2022
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 50 (5), 1303-1314
- https://doi.org/10.1042/bst20220204
Abstract
Parkinson's disease (PD) is a common neurodegenerative condition affecting a significant number of individuals globally, resulting in the presentation of debilitating motor and non-motor symptoms, including bradykinesia, resting tremor, as well as mood and sleep disorders. The pathology of PD has been observed to spread through the central nervous system resulting in progressive brain degeneration and a poor prognosis. Aggregated forms of the protein α-synuclein, particularly intermediary aggregates, referred to as oligomers, or preformed fibrils, have been implicated as the causative agent in the degeneration of neuronal processes, including the dysfunction of axonal transport, mitochondrial activity, and ultimately cellular death. Extracellular vesicles (EVs) have been strongly implicated in the propagation of PD pathology. Current observations suggest that aggregated α-synuclein is transported between neurons via small EVs in a series of exocytosis and endocytosis cellular processes leading to the observed spread of neurotoxicity and cellular death. Despite some understanding of the role of EVs in neurodegeneration, the exact mechanism by which these lipidic particles participate in the progression of Parkinson's pathology is not entirely understood. Here we review the current understanding of the role of EVs in the propagation of PD and explore their potential as a therapeutic target.Keywords
This publication has 119 references indexed in Scilit:
- Neurotransmitter-Triggered Transfer of Exosomes Mediates Oligodendrocyte–Neuron CommunicationPLoS Biology, 2013
- Neuroprotective Function of DJ-1 in Parkinson’s DiseaseOxidative Medicine and Cellular Longevity, 2013
- Exosomal cell-to-cell transmission of alpha synuclein oligomersMolecular Neurodegeneration, 2012
- Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathyMolecular Neurodegeneration, 2012
- -Synuclein in Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Sumoylation inhibits α-synuclein aggregation and toxicityThe Journal of cell biology, 2011
- Effects of Curvature and Composition on α-Synuclein Binding to Lipid VesiclesBiophysical Journal, 2010
- α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in VitroScience, 2010
- Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in SynucleinopathiesOnline Journal of Public Health Informatics, 2010
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after EndocytosisNeuron, 2010